Deep learning for healthcare: review, opportunities and challenges

R Miotto, F Wang, S Wang, X Jiang… - Briefings in …, 2018 - academic.oup.com
Gaining knowledge and actionable insights from complex, high-dimensional and
heterogeneous biomedical data remains a key challenge in transforming health care …

[HTML][HTML] Deep learning for electronic health records: A comparative review of multiple deep neural architectures

JRA Solares, FED Raimondi, Y Zhu, F Rahimian… - Journal of biomedical …, 2020 - Elsevier
Despite the recent developments in deep learning models, their applications in clinical
decision-support systems have been very limited. Recent digitalisation of health records …

Evaluating eligibility criteria of oncology trials using real-world data and AI

R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - nature.com
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging,–. Here we systematically evaluate the effect of …

Deep patient: an unsupervised representation to predict the future of patients from the electronic health records

R Miotto, L Li, BA Kidd, JT Dudley - Scientific reports, 2016 - nature.com
Secondary use of electronic health records (EHRs) promises to advance clinical research
and better inform clinical decision making. Challenges in summarizing and representing …

Distilling large language models for matching patients to clinical trials

M Nievas, A Basu, Y Wang… - Journal of the American …, 2024 - academic.oup.com
Objective The objective of this study is to systematically examine the efficacy of both
proprietary (GPT-3.5, GPT-4) and open-source large language models (LLMs)(LLAMA 7B …

Examining the use of real‐world evidence in the regulatory process

BK Beaulieu‐Jones, SG Finlayson… - Clinical …, 2020 - Wiley Online Library
The 21st Century Cures Act passed by the United States Congress mandates the US Food
and Drug Administration to develop guidance to evaluate the use of real‐world evidence …

Utilization of EHRs for clinical trials: a systematic review

LR Kalankesh, E Monaghesh - BMC Medical Research Methodology, 2024 - Springer
Background and objective Clinical trials are of high importance for medical progress. This
study conducted a systematic review to identify the applications of EHRs in supporting and …

Deep learning in pharmacogenomics: from gene regulation to patient stratification

AA Kalinin, GA Higgins, N Reamaroon… - …, 2018 - Taylor & Francis
This Perspective provides examples of current and future applications of deep learning in
pharmacogenomics, including: identification of novel regulatory variants located in …

Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map

GK Frampton, J Shepherd, K Pickett, G Griffiths… - Trials, 2020 - Springer
Background Recruiting and retaining participants in randomised controlled trials (RCTs) is
challenging. Digital tools, such as social media, data mining, email or text-messaging, could …

NLI4CT: Multi-evidence natural language inference for clinical trial reports

M Jullien, M Valentino, H Frost, P O'Regan… - arxiv preprint arxiv …, 2023 - arxiv.org
How can we interpret and retrieve medical evidence to support clinical decisions? Clinical
trial reports (CTR) amassed over the years contain indispensable information for the …